We are live on ! Find out more
ML

McAdam LLC Portfolio holdings

AUM $2.22B
1-Year Est. Return 16.98%
This Fund
S&P 500
This Quarter Est. Return
+1.6%
1 Year Est. Return
+16.98%
3 Year Est. Return
+46.26%
5 Year Est. Return
+42.13%
10 Year Est. Return
AUM
$246M
AUM Growth
+$27.9M
Cap. Flow
+$24.9M
Cap. Flow %
10.14%
Top 10 Hldgs %
64.81%
Holding
904
New
61
Increased
149
Reduced
132
Closed
202

Sector Composition

1 Technology 1.2%
2 Healthcare 1.18%
3 Consumer Discretionary 0.7%
4 Communication Services 0.61%
5 Industrials 0.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RS icon
776
Reliance Steel & Aluminium
RS
$20.2B
-8
Closed -$1K
RYAAY icon
777
Ryanair
RYAAY
$33.2B
$0 ﹤0.01%
10
SAN icon
778
Banco Santander
SAN
$193B
$0 ﹤0.01%
34
ECHO
779
EchoStar
ECHO
$26.8B
$0 ﹤0.01%
6
SBGI icon
780
Sinclair Inc
SBGI
$1.02B
-60
Closed -$2K
SEIC icon
781
SEI Investments
SEIC
$12B
$0 ﹤0.01%
2
SH icon
782
ProShares Short S&P500
SH
$881M
-625
Closed -$76K
SHE icon
783
State Street SPDR MSCI USA Gender Diversity ETF
SHE
$317M
-4
Closed
SHV icon
784
iShares 0-1 Year Treasury Bond ETF
SHV
$20.9B
-115
Closed -$13K
SKT icon
785
Tanger
SKT
$4.81B
-47
Closed -$1K
SLDB icon
786
Solid Biosciences
SLDB
$874M
-3
Closed
SLNG icon
787
Stabilis Solutions
SLNG
$71.8M
$0 ﹤0.01%
3
SNA icon
788
Snap-on
SNA
$21.5B
-16
Closed -$2K
SNOA icon
789
Sonoma Pharmaceuticals
SNOA
$5.79M
0
SNX icon
790
TD Synnex
SNX
$19.4B
-32
Closed -$2K
SPG icon
791
Simon Property Group
SPG
$75B
-3
Closed
SRPT icon
792
Sarepta Therapeutics
SRPT
$1.82B
-80
Closed -$6K
STAA icon
793
STAAR Surgical
STAA
$1.26B
-34
Closed -$1K
SSYS icon
794
Stratasys
SSYS
$711M
-26
Closed -$1K
STE icon
795
Steris
STE
$21.4B
-24
Closed -$2K
STLD icon
796
Steel Dynamics
STLD
$34B
-25
Closed -$1K
STZ icon
797
Constellation Brands
STZ
$23.1B
-26
Closed -$6K
SVXY icon
798
ProShares Short VIX Short-Term Futures ETF
SVXY
$220M
$0 ﹤0.01%
20
SWX icon
799
Southwest Gas
SWX
$6.77B
-34
Closed -$2K
TFX icon
800
Teleflex
TFX
$6B
-6
Closed -$2K

Similar funds

McAdam LLC's Q2 2018 Portfolio in Review

As of Q2 2018, McAdam LLC held 904 positions worth $246M, up 13% from $218M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

McAdam LLC deployed $24.9M of net new capital in Q2 2018, opening 61 new positions and adding to 149 existing holdings. Its largest new stake was BrightSpire Capital: 7,203 shares worth $149K.

By sector, the portfolio is most concentrated in Technology at 1.2% of assets, down from 1.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $131K trimmed.

  • McAdam LLC's largest Q2 2018 buy was BrightSpire Capital: 7,203 shares worth $149K.
  • McAdam LLC added most to Schwab Fundamental US Large Company Index ETF in Q2 2018, an estimated $2.75M increase.
  • McAdam LLC's biggest Q2 2018 reduction was Vertex Pharmaceuticals, cutting an estimated $131K.
  • McAdam LLC fully exited ProShares Short S&P500 in Q2 2018, selling an estimated $76K.
  • McAdam LLC's ten largest holdings make up 65% of its $246M portfolio in Q2 2018.
  • McAdam LLC opened 61 new positions and closed 202 in Q2 2018.
  • McAdam LLC's portfolio value rose 13% quarter-over-quarter to $246M.

Based on McAdam LLC's 13F filing for Q2 2018, filed 22 Aug 2018.